Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.5022
-0.0389-7.19%
Post-market: 0.4903-0.0119-2.37%19:57 EST
Volume:3.82M
Turnover:1.94M
Market Cap:57.25M
PE:-0.79
High:0.5266
Open:0.5200
Low:0.4950
Close:0.5411
52wk High:4.28
52wk Low:0.2522
Shares:114.00M
Float Shares:111.00M
Volume Ratio:0.98
T/O Rate:3.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6355
EPS(LYR):-0.9026
ROE:-916.17%
ROA:-173.70%
PB:-124.69
PE(LYR):-0.56

Loading ...

Company Profile

Company Name:
Reviva Pharmaceuticals Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
14
Office Location:
10080 N. Wolfe Road,Suite SW3-200,Cupertino,California,United States
Zip Code:
95014
Fax:
408-904-6270
Introduction:
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

Directors

Name
Position
Laxminarayan Bhat
Director,President and Chief Executive Officer
Parag Saxena
Independent Director and Chairman
Les Funtleyder
Independent Director
Purav Patel
Independent Director
Richard Margolin
Independent Director

Shareholders

Name
Position
Laxminarayan Bhat
Director,President and Chief Executive Officer
Narayan Prabhu
Chief Financial Officer